Table 1 Association between the copy number amplification of FAM84B levels and clinicopathological variables in ESCC patients.
Clinic features | FAM84BAmp ≥ 0.5 | FAM84Bnon-Amp < 0.5 | p-valuea |
|---|---|---|---|
All cases | 109 (21.50%) | 398 (78.50%) | |
Age | |||
<60 | 51 (23.29%) | 168 (76.71%) | 0.53 |
≥60 | 58 (20.14%) | 230 (79.86%) | |
Sex | |||
Female | 38 (20.09%) | 134 (77.91%) | 0.90 |
Male | 71 (21.19%) | 264 (78.81%) | |
Location | |||
Upper | 8 (30.77%) | 18 (69.23%) | 0.41 |
Middle | 65 (20.19%) | 257 (79.81%) | |
Lower | 36 (22.64%) | 123 (77.36%) | |
Smoking status | |||
Never | 56 (22.13%) | 197 (77.87%) | 0.81 |
Yes | 53 (20.87%) | 201 (79.13%) | |
Drinking status | |||
Never | 76 (21.97%) | 270 (78.03%) | 0.79 |
Yes | 33 (20.5%) | 128 (79.5%) | |
Histological grade | |||
Grade1 | 8 (17.78%) | 37 (82.22%) | 0.81 |
Grade2 | 76 (21.78%) | 273 (78.22%) | |
Grade3 | 25 (22.12%) | 88 (77.88%) | |
Pathologic stage | |||
I&II | 52 (16.25%) | 268 (83.75%) | 0.0003 |
III | 57 (30.48%) | 130 (69.52%) | |
Prognosis (Log-rank test) | |||
Deceased | 63 (28.90%) | 155 (71.10%) | 0.0011 |
Living | 42 (15.38%) | 231 (84.62%) | |
Missing | 4 (25%) | 12 (75%) |
